Stock Taper
SCREENER COMPARE ANY 2 STOCKS
APGE
APOGEE THERAPEUTICS, INC.
NASDAQ
$135.07
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$8.36 B
52w High$135.09
52w Low$35.39
Dividend Yield—
Frequency—
P/E-31.19
Volume0
Shares Out.61.88M

COMPANY

LEADERSHIP

Michael Thomas Henderson
CHIEF EXECUTIVE
Michael Thomas Henderson

COMPENSATION 2026

Salary$700,000
Stock Awards$0
Incentive Plan Pay$591,500
All Other Comp.$0
Total$1,291,500

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 14, 2023
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
261

PRICE TARGET

Target High$140.00
Target Low$89.00
Target Median$135.00
Target Consensus$130.92

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$10.00M
NOV
9
MON

PRICE

$135.07 ▲ UP 0.00% (+$0.00)
$135$135$135$1359:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM135.07

About Apogee Therapeutics, Inc.

https://www.apogeetherapeutics.com ↗

Apogee Therapeutics, founded in 2022 in Waltham, MA, develops biologics like monoclonal antibodies for atopic dermatitis, COPD, and inflammatory conditions, including products like APG777 and APG808.

INDUSTRY

Biotechnology

A PRODUCT APOGEE THERAPEUTICS, INC. IS KNOWN FOR

Zumilokibart (APG777)
Zumilokibart (APG777)

Zumilokibart is an innovative, half-life extended anti-IL-13 antibody in clinical trials for atopic dermatitis, asthma, and inflammatory diseases, aiming to become a best-in-class treatment and reshape immunological care.

COMPETITORS

COMPETITOR
AMGN COMPARE
LLY COMPARE
PFE COMPARE
REGN COMPARE
SNY COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
136
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.01% · 1.9M
XBI
1.49% · 1.3M
IWM
0.20% · 1.1M
SCHA
0.16% · 266.1K
SBIO
4.29% · 76.3K
FPX
0.45% · 48.9K
FESM
0.10% · 47.9K
LABU
1.00% · 42.7K
XRSU.L
0.20% · 41.1K
MNA
1.33% · 25.3K
RSSL
0.19% · 21.5K
IPO
1.90% · 20.1K
JSML
0.53% · 14.5K
BBSC
0.21% · 11.6K
PRFZ
0.06% · 11.4K
BKMC
0.18% · 8.8K
GSSC
0.08% · 6.6K
RTWO.L
0.17% · 2.8K
MRGR
2.32% · 2.7K
STXK
0.34% · 2.1K
RFLR
0.25% · 1.8K
TILT
0.01% · 972
VETS
0.25% · 923
USFMDN.MX
0.01% · 216
RESM
0.25% · 111
AVLC
0.00% · 106

INSTITUTIONAL OWNERSHIP

SHARES OWNED
91.36%
HOLDERS
364
TOP 12 OF 364 · RANKED BY POSITION SIZE
T. Rowe Price Investment Management, Inc.
10.3M sh · $867.03M
Fmr LLC
9.3M sh · $779.61M
Vr Adviser, LLC
8.5M sh · $1.13B
Blackrock, Inc.
5.5M sh · $730.95M
Wellington Management Group Llp
4.7M sh · $358.27M
Vanguard Group Inc
2.9M sh · $215.71M
Hbk Investments L P
2.9M sh · $378.28M
Rtw Investments, LP
2.8M sh · $234.17M
Blackrock Inc.
2.7M sh · $107.92M
Janus Henderson Group Plc
2.4M sh · $198.81M
Perceptive Advisors LLC
2.3M sh · $175.92M
State Street Corp
2.3M sh · $304.98M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Fairmount Funds Management LLC
Purchase · 10.4K shares
2026-08-07
★
DIRECTOR
Fairmount Funds Management LLC
Sale · 31.8K shares
2026-08-07
★
DIRECTOR
Fairmount Funds Management LLC
Purchase · 31.8K shares
2026-08-07
★
DIRECTOR
Fairmount Funds Management LLC
Sale · 10.4K shares
2026-08-07

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 6
HOLD 5
SECTOR PERFORM 1
12 GRADES IN THE LAST 12 MONTHS
Truist Securities HOLD BTIG NEUTRAL Mizuho NEUTRAL Stifel HOLD TD Cowen HOLD Guggenheim NEUTRAL Wedbush NEUTRAL Citigroup NEUTRAL

SECTORS PEERS

PEERPRICE
CGON$74.35COMPARE
XENE$60.29COMPARE
CELC$95.67COMPARE
LEGN$21.75COMPARE
ZLAB$27.04COMPARE
IRON$79.20COMPARE
RARE$14.68COMPARE
AAPG$17.58COMPARE